Need for treatment intensification Over 50% of T2D patients require insulin after 6 years Bergenstal 2001; Wright 2002 2
Citation preview
Insulin Initiation With NovoMix30
Masoud Rahmanian MD Need for treatment intensification
Over 50% of T2D patients require insulin after 6 years Bergenstal
2001; Wright 2002 2 Current diabetes targets and guidelines
Insulin therapy with NovoMix 30 Current diabetes targets and
guidelines 26 April, 2017 HbA1c targets are converging
Insulin therapy with NovoMix 30 Good glycaemic control ADA/EASD
consensus HbA1c 10.0 % 9.5 20.2% have HbA1c>9.0 % 9.0 8.5 37.2%
have HbA1c>8.0 % 8.0 7.5 64.2% of patients with type 2 diabetes
have HbA1c7.0 % 7.0 6.5 6.0 5.5 Adapted from Unger et al. Am J Med
2008;121:S3S8. 26 April, 2017 7 Current glycaemic targets
Insulin therapy with NovoMix 30 Current HbA1c goals include: ADA,
EASD, IDF:
